Microbiological Aspects of Pharmaceutical Manufacturing of Adipose-Derived Stem Cell-Based Medicinal Products
Cells · 21.02.2023 · 12 (5) · 680
DOI: 10.3390/cells12050680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 21.02.2023. Verfasst von Ilona Szabłowska-Gadomska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Cell Research and Application, Center for Preclinical Research and Technology, Medical University of Warsaw, Banacha 1b, 02-097 Warsaw…. Hauptthemen laut MEDLINE: Cell- and Tissue-Based Therapy, Stem Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Center for Research and Development, Ministry of Science and Higher Education in Poland.
Abstract (Originalsprache)
Subcutaneous adipose tissue is an excellent source of mesenchymal stem cells (ADSCs), which can be used in cell therapies as an active substance in advanced therapy medicinal products (ATMPs). Because of the short shelf-life of ATMPs and the time needed to obtain the results of microbiological analysis, the final product is often administered to the patient before sterility is confirmed. Because the tissue used for cell isolation is not sterilized to maintain cell viability, controlling and ensuring microbiological purity at all stages of production is crucial. This study presents the results of monitoring the contamination incidence during ADSC-based ATMP manufacturing over two years. It was found that more than 40% of lipoaspirates were contaminated with thirteen different microorganisms, which were identified as being physiological flora from human skin. Such contamination was successfully eliminated from the final ATMPs through the implementation of additional microbiological monitoring and decontamination steps at various stages of production. Environmental monitoring revealed incidental bacterial or fungal growth, which did not result in any product contamination and was reduced thanks to an effective quality assurance system. To conclude, the tissue used for ADSC-based ATMP manufacturing should be considered contaminated; therefore, good manufacturing practices specific to this type of product must be elaborated and implemented by the manufacturer and the clinic in order to obtain a sterile product.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Cell Research and Application, Center for Preclinical Research and Technology, Medical University of Warsaw, Banacha 1b, 02-097 Warsaw, Poland.
- BBMRI.pl Consortium, 61 Żwirki i Wigury Street, 02-091 Warsaw, Poland.
- Department of Histology and Embryology, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, Poland.
- Polish Stem Cell Bank (PBKM), Jana Pawła II 29, 00-867 Warsaw, Poland.
ORCID-Profile: Ilona Szabłowska-Gadomska, Monika Humięcka, Joanna Brzezicka, Anna Chróścicka, Joanna Płaczkowska, Malgorzata Lewandowska-Szumiel
Förderung
- National Center for Research and Development
- Ministry of Science and Higher Education in Poland
Zitieren
APA
Szabłowska-Gadomska, I., Humięcka, M., Brzezicka, J., Chróścicka, A., Płaczkowska, J., Ołdak, T., & Lewandowska-Szumiel, M. (2023). Microbiological Aspects of Pharmaceutical Manufacturing of Adipose-Derived Stem Cell-Based Medicinal Products. Cells, 12(5), 680. https://doi.org/10.3390/cells12050680
Vancouver
Szabłowska-Gadomska I, Humięcka M, Brzezicka J, Chróścicka A, Płaczkowska J, Ołdak T, et al. Microbiological Aspects of Pharmaceutical Manufacturing of Adipose-Derived Stem Cell-Based Medicinal Products. Cells. 2023;12(5):680. doi:10.3390/cells12050680
BibTeX
@article{SzabowskaGadomska2023,
author = {Szabłowska-Gadomska, Ilona and Humięcka, Monika and Brzezicka, Joanna and Chróścicka, Anna and Płaczkowska, Joanna and Ołdak, Tomasz and Lewandowska-Szumiel, Malgorzata},
title = {Microbiological Aspects of Pharmaceutical Manufacturing of Adipose-Derived Stem Cell-Based Medicinal Products},
journal = {Cells},
year = {2023},
volume = {12},
number = {5},
pages = {680},
doi = {10.3390/cells12050680}
}
EUVIMED